Mirena 20MCG/24HR 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTLP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,921
Award facts
- Contract value 100% obligated
- $27,921.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,921.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 20 mcg/24hr contraceptive devices. The delivery order, issued on January 14, 2026, with an ultimate completion date of February 3, 2026, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group Inc. serves as a critical pharmaceutical supplier within the federal military medical supply chain, maintaining a single-award IDC valued at $499,999,999 through December 31, 2036, which encompasses a 30-month base period and three 30-month option periods. The company's established performance across diverse therapeutic categories—including oncology treatments, biologics, vaccines, specialty pharmaceuticals, and medical consumables—positions it as a capable regional prime vendor contractor under the broader PPV-G GEN V framework. The Mirena delivery order represents one of numerous awards issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division, reflecting the contractor's consistent ability to fulfill specialized pharmaceutical requirements for Department of Defense operations.
Quick answers
Who was awarded contract SPE2DR26FBTLP?
SPE2DR26FBTLP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FBTLP worth?
The government has obligated $27,921 on SPE2DR26FBTLP.
Is contract SPE2DR26FBTLP an order under another contract?
Yes. SPE2DR26FBTLP is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTLP competed?
The extent of competition for SPE2DR26FBTLP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award